Artifact Capital
VC Fund
Minneapolis, United States
Artifact Capital is a VC fund in Minneapolis focused on Artificial Intelligence and Machine Learning. Investment Management Firm
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Artifact Capital invests in
Artificial IntelligenceMachine LearningSaaSBeautyMedical
Stages Artifact Capital invests in
Series ASeedFunding RoundPre-Seed
Countries Artifact Capital invests in
United States
Investment Focus
Industry
- Artificial Intelligence 3 (33%)
- Machine Learning 2 (22%)
- SaaS 1 (11%)
- Beauty 1 (11%)
- Medical 1 (11%)
Stage
- Series A 3 (33%)
- Seed 2 (22%)
- Funding Round 2 (22%)
- Pre-Seed 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LUUM
|
LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application. | $30M / Series A / Aug 15, 2024 | |
Bucha Bio
|
Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more.Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product. | Seed / Apr 01, 2023 | |
Axiom Cloud
|
Axiom Cloud uses AI to solve the biggest energy and maintenance problems plaguing the underserved commercial cooling and refrigeration industry. Their first target customer segment is retail grocery. Customers pay an initial setup fee to install and configure the IoT platform onsite, along with recurring SaaS fees for one or more cloud-basedsoftware apps that run on the IoT platform.The company was founded in 2020 and is based in Oakland, California, United States. | $7.4M / Series A / Jan 18, 2023 | |
Quarrio
|
Quarrio is a deterministic enterprise AI platform that runs on CPUs as well as GPUs, avoiding the cost and capacity bottlenecks of GPU‑only GenAI while delivering infrastructure‑grade reliability. Acting as a deterministic execution layer for enterprise AI, it turns natural‑language questions into fully traceable actions on structured systems,delivering 100% accurate, auditable answers and workflows in seconds instead of weeks.Built by the pioneers who created SQL, Symantec, and IBM WatsonWhere probabilistic GenAI generates “likely” answers with inherent hallucination risk, Quarrio guarantees same input, same output and never guesses, which is essential when AI approves transactions, triggers capital allocations, or executes workflows. Every result maps to verifiable database calls across CRM, ERP, financial, risk, and other systems, with full transparency and SQL‑level audit trails that regulators, boards, and auditors can trust.Quarrio’s deterministic AI provides the trusted backbone that probabilistic GenAI systems lack, supplying the trust layer required for safe enterprise‑scale automation. Designed as capital‑efficient AI infrastructure, it keeps sensitive data in place, reduces GPU and data‑export risk, and compresses decision latency from days or weeks to seconds, enabling measurable ROI and durable competitive advantage. | $3.2M / Jan 01, 2023 | |
|
LUUM
|
LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application. | Jul 12, 2022 | |
|
LUUM
|
LUUM is introducing automation to the beauty-services market, initially focusing on eyelash extensions, a widely popular treatment ($20B global market opportunity). Pioneering a patented combination of robotics, AI, and machine vision, LUUM applies a full set of eyelash extensions in 20 minutes (instead of 2 hours), while eliminating the costsand safety risks associated with human application. | $2.9M / Seed / Jul 12, 2022 | |
|
Quarrio
|
Quarrio is a deterministic enterprise AI platform that runs on CPUs as well as GPUs, avoiding the cost and capacity bottlenecks of GPU‑only GenAI while delivering infrastructure‑grade reliability. Acting as a deterministic execution layer for enterprise AI, it turns natural‑language questions into fully traceable actions on structured systems,delivering 100% accurate, auditable answers and workflows in seconds instead of weeks.Built by the pioneers who created SQL, Symantec, and IBM WatsonWhere probabilistic GenAI generates “likely” answers with inherent hallucination risk, Quarrio guarantees same input, same output and never guesses, which is essential when AI approves transactions, triggers capital allocations, or executes workflows. Every result maps to verifiable database calls across CRM, ERP, financial, risk, and other systems, with full transparency and SQL‑level audit trails that regulators, boards, and auditors can trust.Quarrio’s deterministic AI provides the trusted backbone that probabilistic GenAI systems lack, supplying the trust layer required for safe enterprise‑scale automation. Designed as capital‑efficient AI infrastructure, it keeps sensitive data in place, reduces GPU and data‑export risk, and compresses decision latency from days or weeks to seconds, enabling measurable ROI and durable competitive advantage. | Pre-Seed / Oct 01, 2021 | |
|
Quarrio
|
Quarrio is a deterministic enterprise AI platform that runs on CPUs as well as GPUs, avoiding the cost and capacity bottlenecks of GPU‑only GenAI while delivering infrastructure‑grade reliability. Acting as a deterministic execution layer for enterprise AI, it turns natural‑language questions into fully traceable actions on structured systems,delivering 100% accurate, auditable answers and workflows in seconds instead of weeks.Built by the pioneers who created SQL, Symantec, and IBM WatsonWhere probabilistic GenAI generates “likely” answers with inherent hallucination risk, Quarrio guarantees same input, same output and never guesses, which is essential when AI approves transactions, triggers capital allocations, or executes workflows. Every result maps to verifiable database calls across CRM, ERP, financial, risk, and other systems, with full transparency and SQL‑level audit trails that regulators, boards, and auditors can trust.Quarrio’s deterministic AI provides the trusted backbone that probabilistic GenAI systems lack, supplying the trust layer required for safe enterprise‑scale automation. Designed as capital‑efficient AI infrastructure, it keeps sensitive data in place, reduces GPU and data‑export risk, and compresses decision latency from days or weeks to seconds, enabling measurable ROI and durable competitive advantage. | $3.9M / Oct 01, 2021 | |
MyMeds
|
MyMeds is redefining the medication experience through real-time data exchange. They offers patients can auto-import their meds and set up med reminder services. | Series A / Jan 01, 2021 |
Co-Investors
Foundation Capital
3 deals together
SaxeCap
2 deals together
Ulta Beauty
2 deals together
XSeed Capital
2 deals together
Ascendant Venture
1 deal together
Blue Bear Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Health Care Investors
43,014 investors
Artificial intelligence Investors
40,702 investors
Marketplace Investors
40,654 investors
Consumer Investors
32,380 investors
Medical Investors
18,848 investors
Machine Learning Investors
17,935 investors
Beauty Investors
4,097 investors
SaaS VC Funds
61,208 investors
FAQ
What does Artifact Capital invest in?
Artifact Capital invests primarily in Artificial Intelligence, Machine Learning and SaaS startups, most often at Series A and Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Artifact Capital last invest?
The most recent investment recorded for Artifact Capital closed in Aug 2024. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
